itial introduction of Sayana® Press in Burkina Faso brings injectable contraceptives to the most peripheral level of the health system and integrates them for the first time into regular community health outreach. Sayana® Press will be delivered by mobile health workers in four regions where a large proportion of women have expressed a desire to prevent or delay pregnancy, but have limited access to contraceptives. The initiative aims to help Burkina Faso meet its goal of increasing contraceptive use among married women from 15 percent in 2010 to 25 percent by 2015.
Burkina Faso’s introduction activities are being implemented by the country’s Ministry of Health and key partner organizations, including UNFPA, Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), Marie Stopes International (MSI), and the Association Burkinabé pour le Bien-Etre Familial (ABBEF), with technical support from PATH.
The global initiative to support Sayana Press introduction was launched at the 2012 London Summit on Family Planning as part of a larger effort to ensure that voluntary family planning information, contraceptives, and services reach 120 million more women and girls in the world’s poorest countries by 2020.
The Sayana® Press introductions, which are coordinated by PATH, are based on the principle that all women, no matter where they live, should have access to a range of contraceptive options that enable them to make an informed choice and meets their needs.
Pfizer’s Chief Medical Officer Dr. Freda Lewis-Hall remarked, “At Pfizer, we strive to improve the health of people worldwide, and, as part of that, we’re committed to increasing access in developing countries to our portfolio. While the industry can take the lead in developing products suited to the needs of the market, it is largely through innovative private-public partnerships such as this that we can ensure the long-term viability of supply and distrib
Page: 1 2 3 4 5 6 Related biology technology :1
Copyright©2014 Vocus, Inc.
All rights reserved
. New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 20192
. European Injectable Drug Delivery Report 2013: Market Forecasts to 20173
. Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 20174
. North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 20175
. A bright idea: Tiny injectable LEDs help neuroscientists study the brain6
. North American Injectable Drug Delivery Market worth $16.6 Billion by 20177
. Mylan to Acquire Agila to Create Leading Global Injectables Platform8
. Using 3-D printing and injectable molds, bioengineered ears look and act like the real thing9
. New injectable hydrogel encourages regeneration and improves functionality after a heart attack 10
. Contraceptives Market is Expected to Reach USD 23.3 Billion Globally in 2018: Transparency Market Research11
. HerKare Launched To Exclusively Treat Hormone Imbalance In Women